This trial will help explain why black individuals are at increased cardiovascular disease risk and if mitochondrial reactive oxygen species play a role in this.
6 Primary · 7 Secondary · Reporting Duration: Before and one hour after supplementation or placebo
60 Total Participants · 2 Treatment Groups
Primary Treatment: MitoQ · Has Placebo Group · N/A
Age 19 - 75 · All Participants · 6 Total Inclusion CriteriaMark “Yes” if the following statements are true for you: